What You Should Know: - Digital health company Sharecare and special purpose acquisition company (SPAC), Falcon Capital Acquisition Corp, today announced an agreement to merge to go public on the NASDAQ under the ticker symbol SHCR at enterprise value of $3.9B. - The transaction is expected to be funded through a combination of Falcon s $345 million of cash in trust (assuming no redemptions) supported by a $425 million fully committed PIPE at $10.00 per share and the Anthem
First published on
The calendar signals a new year, but the medtech industry in 2021 will feel the lingering effects, both positive and negative, from the novel coronavirus pandemic.
With the resurgence of the virus and emergence of new, more contagious strains, COVID-19 will have major impacts on companies much as in 2020, albeit with the benefit of insights gleaned from the historic year and its unprecedented business environment.
Earlier this month, medtech and diagnostics companies gathered virtually to discuss 2021 prospects at J.P. Morgan s annual healthcare conference. Executives painted a mixed picture, with the first half of the year looking bumpier than the second half.
/Global Medical Device Connectivity Market Future Scope, Development, Revenue and Growth Factors up to 2026|| GENERAL ELECTRIC COMPANY; Cisco; Koninklijke Philips N.V.; iHealth Labs Inc.; Capsule Technologies, Inc.; Baxter
Global Medical Device Connectivity Market Future Scope, Development, Revenue and Growth Factors up to 2026|| GENERAL ELECTRIC COMPANY; Cisco; Koninklijke Philips N.V.; iHealth Labs Inc.; Capsule Technologies, Inc.; Baxter
Medical device connectivity market is expected to rise to an estimated value of USD 10.54 billion by 2026 26
Medical device connectivity market is expected to rise to an estimated value of USD 10.54 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the rising adoption of remote monitoring capabilities in healthcare services along with increasing the quality of services and safety of patients.
Operator
Welcome to the Royal Philips Fourth Quarter and Full Year 2020 Results Conference Call on Monday, January 25, 2021. During the call hosted by Mr. Frans van Houten, CEO; and Mr. Abhijit Bhattacharya, all participants will be in a listen-only mode. [Operator Instructions]
I will now hand the conference over to Mr. Leandro Mazzoni, Head of Investor Relations. Please go ahead, sir.
Leandro Mazzoni
Head of Investor Relations
Good morning, ladies and gentlemen. Welcome to Philips fourth quarter and full year 2020 results conference call. I m here with our CEO, Frans van Houten; and our CFO, Abhijit Bhattacharya. On today s call, Frans will take you through our strategic and financial highlights for the period. Abhijit will then provide more detail on the financial performance. And after that, we will take your questions.
Share
This morning Royal Philips announced its plans to acquire med tech Capsule Technologies for a whopping $635 million from Francisco Partners.
Capsule is best known for its suite of connected medical devices and its data integration platform that can combine device integration, vital signs monitoring and clinical surveillance services. The tool was designed to link up medical devices and EHRs via a vendor neutral system.
Over the years the company has also landed several FDA clearances. For example, the Capsule Vitals Plus, which records medical device data and continuous vital signs monitoring. It then analyzes the information at the patient s bedside.